Product information
- Product Line
- Human Formulations
- Category
- Therapeutic Ranges, Cardiac Range
- Dosage Form
- Tablet
- Product Type
- Single Ingredient
Available strengths
Telmisartan 40mg, Cilnidipine 10mg + Mełoprolol 23.75mg (eq. to Metoprolol 25mg) ( )
Description
Telmisartan 40mg, Cilnidipine 10mg + Mełoprolol 23.75mg (eq. to Metoprolol 25mg) Tablets (Film coated) is a tablet formulated with Telmisartan 40mg, Cilnidipine 10mg + Mełoprolol 23.75mg (eq. to Metoprolol 25mg) ( ). The listed active ingredient profile is Telmisartan; Cilnidipine; Mełoprolol, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardiovascular medicines used to lower blood pressure or manage related cardiovascular conditions. The source identifies the dosage form as tablet with film coated presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.